Target intelligence / Profile preview

Mycobacterium tuberculosis DNA (Mtb DNA) (Mtb DNA)

Target
Mtb DNA
Molecular classification
Nucleic acid
01

Overview

Mycobacterium tuberculosis DNA is the genetic material of the bacterium responsible for tuberculosis, encoding all proteins and regulatory RNAs necessary for its complex life cycle and pathogenesis (Nature Reviews Microbiology, 2019). It serves as a critical therapeutic target, both directly through drugs that bind to the DNA polymer and indirectly through the inhibition of enzymes that manage DNA topology and expression. For instance, clofazimine is thought to bind to mycobacterial DNA, particularly guanine residues, to disrupt template function (DrugBank, DB00896), while fluoroquinolones target the DNA-gyrase complex to induce lethal double-strand breaks (StatPearls, 2023). Beyond therapeutics, Mtb DNA is the cornerstone of modern tuberculosis diagnostics, where specific sequences like IS6110 or the rpoB gene are amplified to confirm infection and identify drug-resistance mutations (WHO, 2021). Its high GC content and unique repair mechanisms contribute to the bacterium's ability to persist within host macrophages and develop resistance to conventional treatments.

Other names
Mycobacterium tuberculosis genomeM. tuberculosis DNAMtb chromosomeMtb DNA
02

Mechanism of action

Direct DNA binding and template interference; stabilization of DNA-gyrase cleavage complexes; induction of reactive-oxygen-species-mediated DNA damage.

03

Biological functions

Genetic information storageTemplate for replicationTemplate for transcriptionRegulation of gene expression
04

Disease associations

InfectionTuberculosis
05

Safety considerations

Development of multi-drug resistance (MDR-TB)Potential genotoxicityOff-target effects on host mitochondrial DNASkin pigmentation changes associated with DNA-binding drugs
06

Interacting drugs

Clofazimine

5 more in the full profile.

07

Biomarkers

IS6110 insertion elementrpoB gene mutations (rifampicin resistance)katG gene mutations (isoniazid resistance)gyrA gene mutations (fluoroquinolone resistance)pncA gene mutations (pyrazinamide resistance)

Beyond the preview

Go deeper on Mycobacterium tuberculosis DNA (Mtb DNA) (Mtb DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis DNA (Mtb DNA) (Mtb DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call